Volume 7; Issue Supplement

Shock

Volume 7; Issue Supplement
11

Role of CD14 in Sepsis

Year:
1997
File:
PDF, 107 KB
1997
22

THE ROLE OF SELECTINS IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY

Year:
1997
File:
PDF, 124 KB
1997
23

Cl-inhibitor: From physiological targets to clinical application.

Year:
1997
File:
PDF, 104 KB
1997
24

Inhibition of C5a anaphylatoxin activity in vivo

Year:
1997
File:
PDF, 223 KB
1997
36

Nicotine Therapy in Inflammatory Bowel Disease

Year:
1997
File:
PDF, 111 KB
1997
37

EPIDEMIOLOGY OF HELICOBACTER PYLORI INFECTION

Year:
1997
File:
PDF, 128 KB
1997
38

Cytokine cascades in intraabdominal infection

Year:
1997
File:
PDF, 117 KB
1997
39

PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS

Year:
1997
File:
PDF, 226 KB
1997
44

OVERVIEW OF AVAILABLE HEMOGLOBIN-BASED BLOOD SUBSTITUTES

Year:
1997
File:
PDF, 87 KB
1997
60

GROWTH HORMONE AND THE HEART, WITH A FOCUS ON CARDIOMYOPATHY PATIENTS

Year:
1997
File:
PDF, 132 KB
1997
70

WHAT IS THE ROLE OF IL-6 IN SEPSIS?

Year:
1997
File:
PDF, 123 KB
1997
85

INTERFERON-GAMMA IN INFECTIOUS DISEASES: CLINICAL APPLICATIONS

Year:
1997
File:
PDF, 239 KB
1997
90

MODERN COMPLEMENT ANALYSIS - A DIAGNOSTIC TOOL IN TRAUMA, SIRS AND SEPSIS.

Year:
1997
File:
PDF, 213 KB
1997
92

Diagnosis of Helicobacter pylori infection

Year:
1997
File:
PDF, 128 KB
1997
93

THE DUAL NATURE OF NITRIC OXIDE (NO) IN SIRS

Year:
1997
File:
PDF, 138 KB
1997
101

HYPERTONIC SALINE: POTENTIAL IMMUNOMODULATION

Year:
1997
File:
PDF, 121 KB
1997
107

CYTOKINE MEASUREMENT IN SEPSIS: Getting Around the Pitfalls

Year:
1997
File:
PDF, 123 KB
1997
108

Role of Gene Therapy in Wound Healing

Year:
1997
File:
PDF, 110 KB
1997
112

SIRS, CARS AND MARS CHAOS

Year:
1997
File:
PDF, 122 KB
1997
129

USE OF SERUM CYTOKINE ANALYSIS IN HUMAN SEPSIS

Year:
1997
File:
PDF, 126 KB
1997
138

PROCALCITONIN: NEW DATA and PERSPECTIVES

Year:
1997
File:
PDF, 87 KB
1997
153

LYMPHOCYTE SUBPOPULATIONS IN SEVERE TRAUMA PATIENTS

Year:
1997
File:
PDF, 114 KB
1997
165

Analysis of T and NK repertoire by Flow

Year:
1997
File:
PDF, 106 KB
1997
170

CYTOKINES, RECEPTORS, CELLULAR SIGNALLING AND CONSEQUENCES ON HEART FUNCTION

Year:
1997
File:
PDF, 249 KB
1997
177

Neopterin in acute pancreatitis

Year:
1997
File:
PDF, 121 KB
1997
182

MODERN COMPLEMENT ANALYSIS - A DIAGNOSTIC TOOL IN TRAUMA, SIRS AND SEPSIS.

Year:
1997
File:
PDF, 213 KB
1997
184

Diagnosis of Helicobacter pylori infection

Year:
1997
File:
PDF, 128 KB
1997
187

The value of PCT for diagnostics of severe infections and sepsis In the ICU

Year:
1997
File:
PDF, 124 KB
1997
208

IMMUNONUTRITION

Year:
1997
File:
PDF, 125 KB
1997
216

Adhesion formation as local response to intraabdominal infection

Year:
1997
File:
PDF, 235 KB
1997
223

KINETICS AND CONSEQUENCES OF BLOOD TRANSFUSION

Year:
1997
File:
PDF, 123 KB
1997
232

TWO HIT HYPOTHESIS - TRAUMA-INDUCED

Year:
1997
File:
PDF, 256 KB
1997
235

Molecules for Endotoxin-Removal and Neutralisation

Year:
1997
File:
PDF, 106 KB
1997
242

GASTRIC LYMPHOMAS

Year:
1997
File:
PDF, 113 KB
1997
247

Sensitization to endotoxin by GM-CSF

Year:
1997
File:
PDF, 87 KB
1997
259

GENETICS AND THE IMMUNE SYSTEM IN IBD

Year:
1997
File:
PDF, 106 KB
1997
277

sCrl - Clinical and Experimental Data

Year:
1997
File:
PDF, 104 KB
1997
278

304a THE CLINICAL POTENTIAL OF rHIL-10 IN ISCHEMIA-REPERFUSION INJURY

Year:
1997
File:
PDF, 112 KB
1997
285

BLOOD TRANSFUSIONS PRODUCE HEMATOPOIETIC AND IMMUNE EFFECTS

Year:
1997
File:
PDF, 126 KB
1997
287

Potentiation of antibiotics efficacy with G-CSF

Year:
1997
File:
PDF, 99 KB
1997
289

646

Year:
1997
File:
PDF, 106 KB
1997
298

SOLUBLE TNF RECEPTOR CONSTRUCTS AND SEPSIS

Year:
1997
File:
PDF, 207 KB
1997
303

THE ROLE OF CYTOKINES AND ADHESION MOLECULES IN TRAUMA PATIENTS

Year:
1997
File:
PDF, 113 KB
1997
304

211a THE ROLE OF CHEMOKINES IN ARDS

Year:
1997
File:
PDF, 115 KB
1997
306

THE ROLE OF THE INTESTINE IN SEVERE ABDOMINAL SEPSIS

Year:
1997
File:
PDF, 113 KB
1997
309

Chronic Heart Failure and Dilated Cardiomyopathy.

Year:
1997
File:
PDF, 116 KB
1997
313

MOF, NEUTROPHILS, AND PENTOXIFYLLIN: AN UPDATE

Year:
1997
File:
PDF, 109 KB
1997
317

THE INHIBITORY EFFECT OF ULINASTATIN ON BT

Year:
1997
File:
PDF, 108 KB
1997
324

Attenuation of the inflammatory response by cytokines

Year:
1997
File:
PDF, 243 KB
1997
329

INTERLEUKIN-I INTERFERES WITH THE INDUCTION OF T-CELL ANERGY.

Year:
1997
File:
PDF, 121 KB
1997
333

Clinical Wound Healing Models or Methods

Year:
1997
File:
PDF, 102 KB
1997
339

NEW DEVELOPMENTS IN THE THERAPY OF INFLAMMATORY BOWEL DISEASE (IBD).

Year:
1997
File:
PDF, 109 KB
1997
350

ANTIBIOTICS, ENDOTOXIN AND THE PATHOGENESIS OF GRAM-NEGATIVE SEPSIS

Year:
1997
File:
PDF, 124 KB
1997
372

PROGRESS ON DEVELOPMENT OF A VACCINE FOR HELICOBACTER PYLORI.

Year:
1997
File:
PDF, 113 KB
1997
375

MARKERS OF CANDIDA SEPTICAEMIA

Year:
1997
File:
PDF, 223 KB
1997
381

THE GUT AS A COUNTER-INFLAMMATORY ORGAN

Year:
1997
File:
PDF, 119 KB
1997
382

POLYENE THERAPY FOR CANDIDA INFECTION

Year:
1997
File:
PDF, 121 KB
1997
386

COMPLEMENT INHIBITION

Year:
1997
File:
PDF, 118 KB
1997
392

MIF AND GLUCOCORTICOID MODULATION OF PROINFLAMMATORY CYTOKINE SYNTHESIS

Year:
1997
File:
PDF, 112 KB
1997
398

TARGETING THERAPY TO THE APPROPRIATE POPULATION

Year:
1997
File:
PDF, 120 KB
1997
399

LIPOSOMAL PGE1 MECHANISNS OF ACTION AND EFFECTS IN ARDS

Year:
1997
File:
PDF, 215 KB
1997
403

CONTROLLING THE COMPLEMENT SYSTEM IN INFLAMMATION: INTRODUCTION

Year:
1997
File:
PDF, 113 KB
1997
404

SPECTRUM OF PATHOGENS AND RESISTANCE IN INTENSIVE CARE UNITS

Year:
1997
File:
PDF, 99 KB
1997
411

In vitro and In vivo measurement of staphylococcal virulence

Year:
1997
File:
PDF, 105 KB
1997
419

486a Procalcitonin (PCT) a diagnostic marker in transplantation

Year:
1997
File:
PDF, 111 KB
1997
424

HISTAMINE IN ANAPHYLACTIC/ANAPHYLACTOID REACTIONS

Year:
1997
File:
PDF, 114 KB
1997
426

CURRENT MECHANISTIC AND CLINICAL CONCEPTS ON POUCHITIS

Year:
1997
File:
PDF, 119 KB
1997
427

TRIGGERS - MEDIATORS - RESPONSE CONCEPT IN INTRAABDOMINAL INFECTION

Year:
1997
File:
PDF, 117 KB
1997
436

Molecular Markers of Inflammatory Bowel Disease

Year:
1997
File:
PDF, 106 KB
1997
446

THE TWO-HIT HYPOTHESIS: INFECTION AND ENDOTOXEMIA

Year:
1997
File:
PDF, 234 KB
1997
456

THE MULTIPLE ORGAN DYSFUNCTION (MOD) SCORE

Year:
1997
File:
PDF, 120 KB
1997
457

The Role Of The Bone Marrow

Year:
1997
File:
PDF, 122 KB
1997
467

ARDS Pathogenesis: Role of Nitric Oxide

Year:
1997
File:
PDF, 115 KB
1997
480

BLUNT MYOCARDIAL INJURY: CLINICAL CHARACTERISTICS AND MANAGEMENT

Year:
1997
File:
PDF, 140 KB
1997
481

Strategy of Antibiotic Therapy in Childhood Sepsis

Year:
1997
File:
PDF, 110 KB
1997
482

THE ROLE OF γ-GLOBULINS IN THE TREATMENT OF NEONATAL SEPSIS

Year:
1997
File:
PDF, 110 KB
1997
484

CLINICAL POTENTIAL OF IV ADMINISTERED PERFLUOROCARBONS

Year:
1997
File:
PDF, 129 KB
1997
488

INTRODUCTION TO THE USE OF TNF INHIBITORS IN THE CLINIC

Year:
1997
File:
PDF, 109 KB
1997
489

Clinical Utility of TNF-R I,II assays

Year:
1997
File:
PDF, 129 KB
1997
492

ANTI-ADHESION STRATEGIES FOR THE CONTROL OF SIRS AND THE PREVENTION OF MODS

Year:
1997
File:
PDF, 213 KB
1997
508

648a CLINICAL OUTCOME OF PHASE II STUDIES WITH AT III

Year:
1997
File:
PDF, 114 KB
1997
514

MOLECULAR MECHANISMS IN TOLERANCE TO LPS

Year:
1997
File:
PDF, 112 KB
1997
517

SUCRALPHATE AND BACTERIAL TRANSLOCATION

Year:
1997
File:
PDF, 114 KB
1997
531

323a Biological Properties of IFN-γ-Inducing Factor -IL-18

Year:
1997
File:
PDF, 126 KB
1997
533

SEPTIC CARDIOMYOPATHY

Year:
1997
File:
PDF, 137 KB
1997
543

IMMUNOLOGICAL ENDPOINTS FOR USE IN STUDIES OF INFECTION AFTER TRAUMA

Year:
1997
File:
PDF, 117 KB
1997
549

FACTOR XIII IN CHRONIC INFLAMMATORY BOWEL DISEASE

Year:
1997
File:
PDF, 111 KB
1997
553

Effect of Glutamine on Granulocyte Functions

Year:
1997
File:
PDF, 110 KB
1997
559

ANABOLIC EFFECTS OF GROWTH IN CRITICALLY ILL PATIENTS

Year:
1997
File:
PDF, 113 KB
1997
560

ACUTE RENAL FAILURE

Year:
1997
File:
PDF, 230 KB
1997
561

Quantitation of Human Cytokine mRNAs by Competitive PCR

Year:
1997
File:
PDF, 113 KB
1997
562

POLYVALENT IMMUNE GLOBULINS

Year:
1997
File:
PDF, 127 KB
1997
563

CLINICAL UPDATE FOR rBPI23 (NEUPREXTM)

Year:
1997
File:
PDF, 107 KB
1997
576

NFKB - A NEW MEDIATOR OF SEPSIS

Year:
1997
File:
PDF, 226 KB
1997
581

ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE AND ENDOTHELIAL CELLACTIVATION

Year:
1997
File:
PDF, 124 KB
1997
582

IN VIVO RELEVANCE OF ANTIBIOTIC-INDUCED ENDOTOXIN RELEASE

Year:
1997
File:
PDF, 114 KB
1997
610

COMPLEMENT REGULATORY MOLECULES: AN OVERVIEW.

Year:
1997
File:
PDF, 104 KB
1997
614

G-CSF - an anti-inflammatory cytokine-

Year:
1997
File:
PDF, 113 KB
1997
641

ROLE OF THE IMMUNE SYSTEM IN WOUND HEALING.

Year:
1997
File:
PDF, 110 KB
1997
642

GROWTH FACTORS ASSOCIATED WITH OMENTAL ANGIOGENESIS

Year:
1997
File:
PDF, 113 KB
1997
644

SURGICAL MANAGEMENT OF ACUTE ULCERATIVE COLITIS

Year:
1997
File:
PDF, 119 KB
1997
645

Crohnʼs disease - The concepts of patient individual surgery

Year:
1997
File:
PDF, 243 KB
1997
646

Perianal Crohnʼs Disease - Update on the Operative Management

Year:
1997
File:
PDF, 128 KB
1997
648

Compartmentalisation of inflammation.

Year:
1997
File:
PDF, 117 KB
1997
661

DIAGNOSTICS IN NOSOCOMIAL PNEUMONIA (NP)

Year:
1997
File:
PDF, 106 KB
1997
662

NOSOCOMIAL PNEUMONIA - ANTIBIOTIC STRATEGIES

Year:
1997
File:
PDF, 106 KB
1997
663

ANTIMICROBIAL THERAPY IN NEUTROPENIC PATIENTS

Year:
1997
File:
PDF, 106 KB
1997
664

Nosocomial pneumonia - pharmacoeconomic considerations

Year:
1997
File:
PDF, 106 KB
1997
666

Fc-fragments and their interaction with humoral and cellular receptors

Year:
1997
File:
PDF, 134 KB
1997
670

THE INFLUENCE OF ANTITHROMBIN III (AT III) ON EXPERIMENTAL SEPSIS

Year:
1997
File:
PDF, 215 KB
1997
674

Propofol and Immunomodulation; an in-vitro study

Year:
1997
File:
PDF, 101 KB
1997
676

TRANSLOCATION ACROSS THE GI MUCOSA AS A MECHANISM FOR INFECTION

Year:
1997
File:
PDF, 125 KB
1997
680

TUMOR CELLS AND IMMUNE EFFECTOR SYSTEM: TWO EQUIVALENT COMBATANTS?

Year:
1997
File:
PDF, 106 KB
1997